DuPont (DD)
Forward P/E is 18.26x against a peer median of 17.79x, a ratio of 1.03x — inside the 0.90–1.15 fairly priced band — with trailing P/E 354.67x (the trailing figure is inflated by very low trailing earnings per share after separation-related charges) and PEG 0.94. The latest-quarter revenue change of -44.2% year over year (PRIMARY, EDGAR) is not used as demand evidence: the quarterly series in the filings mixes the old and new company perimeters around the late-2025 separation of the electronics business (now Qnity), so the year-over-year change reflects the changed perimeter, not delivered demand. Judged on the forward P/E ratio against peers plus PEG, the price sits inside the fair band. Delivered demand check: the Conglomerates & diversified services group's median growth was 1.7% year over year — demand steady across the group; this company's own growth figure is not readable across the separation.
What would change this label: Move to OVERVALUED if the forward P/E rises to about 20.5x or above (1.15x the peer median) at unchanged estimates, or if revenue growth in the continuing business, once comparable post-separation figures are reported, falls below 0% year over year for two quarters while the forward multiple stays above 20.5x. Move to UNDERVALUED if the forward P/E compresses to about 16.0x or below (0.90x the peer median) at unchanged estimates.
DuPont makes specialty materials and chemicals used in areas such as clean water, healthcare and industry. Its shares trade at about 18 times expected earnings, in line with similar companies at about 18 times. On that comparison the price looks fair, and the sharp fall in reported sales reflects a business that was split off, not customers disappearing.
Both lines start at 100 on 2020-09-01. Over the full window DuPont returned +94.23% and the S&P 500 +118.28% (price returns; dividends not reinvested). Worst peak-to-trough fall for DuPont: -42.0% (2021-01-12 to 2022-09-26). Source: Nasdaq official daily history.
What the label rests on
Forward P/E is 18.26x against a peer median of 17.79x, a ratio of 1.03x — inside the 0.90–1.15 fairly priced band — with trailing P/E 354.67x (the trailing figure is inflated by very low trailing earnings per share after separation-related charges) and PEG 0.94. The latest-quarter revenue change of -44.2% year over year (PRIMARY, EDGAR) is not used as demand evidence: the quarterly series in the filings mixes the old and new company perimeters around the late-2025 separation of the electronics business (now Qnity), so the year-over-year change reflects the changed perimeter, not delivered demand. Judged on the forward P/E ratio against peers plus PEG, the price sits inside the fair band. Delivered demand check: the Conglomerates & diversified services group's median growth was 1.7% year over year — demand steady across the group; this company's own growth figure is not readable across the separation. The company’s forward P/E is 18.3× against a peer median of 17.8×. Its own history: UNVERIFIED — no sourced range available. Sector demand read: Delivered demand check: the Conglomerates & diversified services group's median latest-quarter revenue growth was 1.7% year over year (SEC filings) — demand steady across the group; this company's own growth figure is not readable across the separation. Latest-quarter sales growth was -44.2% versus a year earlier (SEC filings).
| Company | Price (Oct 28, 2026) | Forward P/E | Trailing P/E |
|---|---|---|---|
| DuPont (DD) | $138.14 | 18.3× | 354.7× |
| LDOS | — | 11.6× | 13.1× |
| CPRT | — | 17.8× | 18.6× |
| HON | — | 22.9× | 9.8× |
| CTAS | — | 37.5× | 42.2× |
| MMM | — | 17.8× | 25.8× |
| Peer median | 17.8× |
Multiples: stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026. Peer set chosen by sector; the median is the middle value of the set. The label and its numbers were recorded in the programme’s label registry on Oct 28, 2026 and will be scored at 6 and 12 months.
Sales, profit and cash
This company does not report a gross-profit line in its SEC facts (normal for banks, payment networks and some health insurers), so profit is shown as net income instead — gross margin is marked UNVERIFIED-absent rather than estimated.
Free cash flow = cash from operations minus spending on plant and equipment, both from the company’s SEC cash-flow statement. Gaps are quarters where that spending line is not separately tagged in the filings — shown as gaps, never estimated.
| Quarter | Sales | Gross margin | Net income | EPS (GAAP, diluted) | Free cash flow |
|---|---|---|---|---|---|
| Q/E Jun 2026 2026-06-30 | $1.8B | — | $143M | 1.05 | $324M |
| Q/E Mar 2026 2026-03-31 | $1.7B | — | $161M | 0.39 | $130M |
| Q/E Dec 2025 2025-12-31 | $1.7B | — | $-126M | -0.30 | $-550M |
| Q/E Sep 2025 2025-09-30 | $3.1B | — | $-123M | -0.29 | $379M |
| Q/E Jun 2025 2025-06-30 | $3.3B | — | $59M | 0.14 | $265M |
| Q/E Mar 2025 2025-03-31 | $3.1B | — | $-589M | -1.41 | $133M |
| Q/E Dec 2024 2024-12-31 | $1.7B | — | $-117M | -0.28 | $403M |
| Q/E Sep 2024 2024-09-30 | $3.2B | — | $454M | 1.08 | $628M |
| Q/E Jun 2024 2024-06-30 | $3.2B | — | $178M | 0.42 | $425M |
| Q/E Mar 2024 2024-03-31 | $2.9B | — | $189M | 0.45 | $286M |
| Q/E Dec 2023 2023-12-31 | $2.9B | — | $-22M | — | $501M |
| Q/E Sep 2023 2023-09-30 | $3.1B | — | $319M | 0.70 | $621M |
The last twelve reported quarters. Full 24-quarter history sits in the data pack behind this page. A dash means the figure is not tagged as a standalone quarter in the company’s SEC facts (the usual case is the fourth quarter, which many companies only report inside the full-year filing) — it is missing, not zero.
Earnings: getting better or worse?
Each box is one quarter’s earnings per share (EPS). Green means EPS was higher than the same quarter a year earlier; red means lower; a dash means the figure is not tagged in the filings.
Basis: GAAP diluted EPS from SEC company facts, compared with the same quarter a year earlier.
Key facts
| Item | Value |
|---|---|
| Company (legal name in filings) | DuPont de Nemours, Inc. |
| Chief executive | Lori Koch (source: http://www.dupont.com/about/leadership/lori-koch.html) |
| Sector | Industrials — Industrial Conglomerates — makes specialty materials and chemicals for clean water, healthcare and industrial uses |
| Share price (Oct 28, 2026) | $138.14 |
| Market value (market cap) | $18.6B — share price times shares outstanding of 135,042,975 (SEC filings; SEC EDGAR dei EntityCommonStockSharesOutstanding (latest)) |
| Sales, last twelve months | $8.3B |
| Net income, last twelve months | $55M |
| Free cash flow, last twelve months | $283M |
| Latest reported quarter | Q/E Jun 2026 (of 24 quarters in the data pack) |
| Six-year price return vs S&P 500 | +94.23% vs +118.28% |
| Worst peak-to-trough fall | -42.0% (2021-01-12 to 2022-09-26) |
What we could not verify
- Gross profit / gross margin: not tagged as a standalone line in this company's EDGAR company facts (common for banks, payment networks and some healthcare payers) — shown as UNVERIFIED-absent; the page charts revenue and net income instead.
- Free cash flow is absent for one or more quarters: either the filer does not separately tag PP&E purchases in its EDGAR cash-flow facts (common for banks), or — for a successor registrant's newest quarter — the cash-flow lines are year-to-date without the prior-quarter rung needed to difference them. Affected quarters are null in the data, never estimated.
- Own-history P/E (5-year median): not computed in the Phase 1 batch — UNVERIFIED
- Year-over-year revenue comparisons cross the late-2025 separation of the electronics business (now Qnity); the filings' quarterly series mixes old and new company perimeters — demand trend not readable from the headline growth figure.
- Guidance record (each quarter scored against the guidance the company gave the quarter before) is not yet compiled for this company — it is a Phase 2 layer. The earnings strip below therefore uses reported EPS versus a year earlier, which is fully sourced from filings.
The IT factor — the most exciting thing the market is overlooking — is not assessed on an X-Ray page. It belongs to the Deep Dive (Phase 2), where it gets the evidence standard it needs. Leadership-era scoring (the six years split by chief executive) is likewise a Phase 2 layer; this page names the current chief executive only, from a sourced profile.
Sources
- SEC EDGAR submissions — Filing index; company legal name.
https://data.sec.gov/submissions/CIK0001666700.json - SEC EDGAR company facts — Quarterly financial spine: revenue, gross profit, net income, GAAP diluted EPS, operating cash flow, PP&E capex, buybacks, dividends, diluted shares.
https://data.sec.gov/api/xbrl/companyfacts/CIK0001666700.json - Nasdaq official daily history — Daily closes for the company; SPY (assetclass=etf) saved as raw/nasdaq_spy_raw.json over identical dates.
https://api.nasdaq.com/api/quote/DD/historical?assetclass=stocks - Valuation multiples and peer figures — stockanalysis.com (SECONDARY, S&P Global data), fetched Oct 28, 2026; see valuation_label.md in the data pack.
Conventions: earliest-filed value per period, as first reported; cash-flow years-to-date differenced quarter by quarter; EPS never differenced; free cash flow = operating cash flow minus plant-and-equipment spending. This page is a dated snapshot — updates are new versions, never silent edits.